Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLoans - NetMinority InterestNon-Current AssetsOther Non-Current AssetsPayablesPrepaid AssetsRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Creative Medical Technology Holdings (CELZ) Notes Payables (2016 - 2021)

Creative Medical Technology Holdings (CELZ) has disclosed Notes Payables for 8 consecutive years, with $2.7 million as the latest value for Q3 2021.

  • On a quarterly basis, Notes Payables rose 201.97% to $2.7 million in Q3 2021 year-over-year; TTM through Sep 2021 was $2.7 million, a 201.97% increase, with the full-year FY2020 number at $788701.0, down 25.75% from a year prior.
  • Notes Payables was $2.7 million for Q3 2021 at Creative Medical Technology Holdings, up from $105000.0 in the prior quarter.
  • In the past five years, Notes Payables ranged from a high of $2.7 million in Q3 2021 to a low of $100000.0 in Q1 2017.
  • A 5-year average of $672221.5 and a median of $682056.0 in 2018 define the central range for Notes Payables.
  • Peak YoY movement for Notes Payables: skyrocketed 763.53% in 2019, then crashed 89.97% in 2021.
  • Creative Medical Technology Holdings' Notes Payables stood at $125000.0 in 2017, then skyrocketed by 445.64% to $682056.0 in 2018, then surged by 55.74% to $1.1 million in 2019, then decreased by 25.75% to $788701.0 in 2020, then soared by 247.84% to $2.7 million in 2021.
  • Per Business Quant, the three most recent readings for CELZ's Notes Payables are $2.7 million (Q3 2021), $105000.0 (Q2 2021), and $327225.0 (Q1 2021).